<!DOCTYPE html>
<html lang="en">

<head>
        <!-- Google tag (gtag.js) -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-5QC942MV32"></script>
    <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'G-5QC942MV32');
    </script>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Genetically encoding multiple functionalities into extracellular vesicles for the targeted delivery of biologics to T cells</title>
    <script src="https://code.jquery.com/jquery-3.7.1.min.js"
        integrity="sha256-/JqT3SQfawRcv/BIHPThkBvs0OEvtFFmqPF/lYI/Cxo=" crossorigin="anonymous"></script>
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap-icons@1.11.2/font/bootstrap-icons.min.css">
    <meta name="description" content="Sadelain, M., Rivière, I. & Riddell, S. Therapeutic T cell engineering. Nature 5">
    <link rel="stylesheet" href="/static/style.css">
</head>

<body onload="related()">
    <nav>
        <div id="logo">NewsFeed</div>
        <a href="/a/business">Business</a>
        <a href="/a/world">World</a>
        <a href="/a/technology">Technology</a>
        <a href="/a/health">Health</a>
        <a href="/a/entertainment">Entertainment</a>
        <i class="bi bi-list" onclick="openNav()"></i>
        <i class="bi bi-search" onclick="openSearch()"></i>
    </nav>

    <div id="mobile-nav">
        <i class="bi bi-x-lg" onclick="closeNav()"></i>
        <a href="/a/business">Business</a>
        <a href="/a/world">World</a>
        <a href="/a/technology">Technology</a>
        <a href="/a/health">Health</a>
        <a href="/a/entertainment">Entertainment</a>
    </div>

    <form action="/search" method="get" id="search">
        <input type="text" name="q" />
        <i class="bi bi-search" onclick="search()"></i>
    </form>

    <div id="wrapper">

        <div class="flex1" id="article">
            <p>Genetically encoding multiple functionalities into extracellular vesicles for the targeted delivery of biologics to T cells</p>
            <span id="topic" >health</span>
                <span class="time">
                    <i class="bi bi-clock"></i><b>Nov-28, 2023</b>
                </span>
                <br><br>
                <img src="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41551-023-01142-x/MediaObjects/41551_2023_1142_Fig1_HTML.png" alt="">

                <textarea id="text" readonly> Sadelain, M., Rivière, I. & Riddell, S. Therapeutic T cell engineering. Nature 545, 423–431 (2017).

Yin, C. et al. In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models. Mol. Ther. 25, 1168–1186 (2017).

Kaminski, R. et al. Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study. Gene Ther. 23, 690–695 (2016).

Dash, P. K. et al. Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat. Commun. 10, 2753 (2019).

Louis Jeune, V., Joergensen, J. A., Hajjar, R. J. & Weber, T. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy. Hum. Gene Ther. Methods 24, 59–67 (2013).

Zincarelli, C., Soltys, S., Rengo, G. & Rabinowitz, J. E. Analysis of AAV serotypes 1–9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073–1080 (2008).

Hamilton, J. R. et al. Targeted delivery of CRISPR–Cas9 and transgenes enables complex immune cell engineering. Cell Rep. 35, 109207 (2021).

Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250–265 (2022).

Segel, M. et al. Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery. Science 373, 882–889 (2021).

Otten, G. R. et al. Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation. Vaccine 24, 4503–4509 (2006).

Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91–96 (2022).

Luther, D. C., Lee, Y. W., Nagaraj, H., Scaletti, F. & Rotello, V. M. Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges. Expert Opin. Drug Deliv. 15, 905–913 (2018).

Liu, C., Zhang, L., Liu, H. & Cheng, K. Delivery strategies of the CRISPR–Cas9 gene-editing system for therapeutic applications. J. Control. Release 266, 17–26 (2017).

Dardalhon, V. et al. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther. 8, 190–198 (2001).

Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).

Soderberg, A., Barral, A. M., Soderstrom, M., Sander, B. & Rosen, A. Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. Free Radic. Biol. Med. 43, 90–99 (2007).

Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341–345 (2011).

Arslan, F. et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 10, 301–312 (2013).

Ohno, S. et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther. 21, 185–191 (2013).

Kojima, R. et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment. Nat. Commun. 9, 1305 (2018).

He, C. et al. Epithelial cell-derived microvesicles: a safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib. Exp. Cell. Res. 392, 112040 (2020).

Chen, R. et al. Friend or foe? Evidence indicates endogenous exosomes can deliver functional gRNA and Cas9 protein. Small 15, e1902686 (2019).

Yao, X. et al. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing. J. Extracell. Vesicles 10, e12076 (2021).

McConnell, R., Y. M. & Finn, J. In International Society for Extracellular Vesicles (Taylor & Francis Online, 2022).

Kooijmans, S. A. et al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J. Control. Release 172, 229–238 (2013).

Théry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).

Knipping, F. et al. Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing. Mol. Ther. 30, 130–144 (2022).

Li, S., Holguin, L. & Burnett, J. C. CRISPR-Cas9-mediated gene disruption of endogenous co-receptors confers broad resistance to HIV-1 in human primary cells and humanized mice. Mol. Ther. Methods in Clin. Dev. 24, 321–331 (2022).

Stranford, D. M., Hung, M. E., Gargus, E. S., Shah, R. N. & Leonard, J. N. A systematic evaluation of factors affecting extracellular vesicle uptake by breast cancer cells. Tissue Eng. Part A 23, 1274–1282 (2017).

Longatti, A. et al. High affinity single-chain variable fragments are specific and versatile targeting motifs for extracellular vesicles. Nanoscale 10, 14230–14244 (2018).

Wang, J. H. et al. Anti-HER2 scFv-directed extracellular vesicle-mediated mRNA-based gene delivery inhibits growth of HER2-positive human breast tumor xenografts by prodrug activation. Mol. Cancer Ther. 17, 1133–1142 (2018).

Kooijmans, S. A. et al. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. J. Extracell. Vesicles 5, 31053 (2016).

Connelly, R. J. et al. Mitogenic properties of a bispecific single-chain Fv-–Ig fusion generated from CD2-specific mAb to distinct epitopes. Int. Immunol. 10, 1863–1872 (1998).

Telerman, A. et al. Internalization of human T lymphocyte receptors. Eur. J. Immunol. 17, 991–997 (1987).

Chang, Z. L. et al. Rewiring T-cell responses to soluble factors with chimeric antigen receptors. Nat. Chem. Biol. 14, 317–324 (2018).

Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3, Unit 3.22 (2006).

Jeppesen, D. K. et al. Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J. Extracell. Vesicles 3, 25011 (2014).

Verweij, F. J. et al. The power of imaging to understand extracellular vesicle biology in vivo. Nat. Methods 18, 1013–1026 (2021).

Simonsen, J. B. Pitfalls associated with lipophilic fluorophore staining of extracellular vesicles for uptake studies. J. Extracell. Vesicles 8, 1582237 (2019).

Hung, M. E. & Leonard, J. N. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery. J. Extracell. Vesicles 5, 31027 (2016).

Bu, J. et al. An avidity-based PD-L1 antagonist using nanoparticle–antibody conjugates for enhanced immunotherapy. Nano Lett. 20, 4901–4909 (2020).

Raab, D., Graf, M., Notka, F., Schödl, T. & Wagner, R. The GeneOptimizer Algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization. Syst. Synth. Biol. 4, 215–225 (2010).

Kooijmans, S. A. A., Gitz-Francois, J., Schiffelers, R. M. & Vader, P. Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach. Nanoscale 10, 2413–2426 (2018).

Yim, N. et al. Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein–protein interaction module. Nat. Commun. 7, 12277 (2016).

Heath, N. et al. Endosomal escape enhancing compounds facilitate functional delivery of extracellular vesicle cargo. Nanomedicine 14, 2799–2814 (2019).

Putyrski, M. & Schultz, C. Protein translocation as a tool: the current rapamycin story. FEBS Lett. 586, 2097–2105 (2012).

Gao, Y. et al. Complex transcriptional modulation with orthogonal and inducible dCas9 regulators. Nat. Methods 13, 1043–1049 (2016).

Maggio, I. et al. Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR–Cas9 components. Gene Ther. 27, 209–225 (2020).

de Jong, O. G. et al. A CRISPR–Cas9-based reporter system for single-cell detection of extracellular vesicle-mediated functional transfer of RNA. Nat. Commun. 11, 1113 (2020).

Hung, M. E., Lenzini, S. B., Stranford, D. M. & Leonard, J. N. Enrichment of extracellular vesicle subpopulations via affinity chromatography. Methods Mol. Biol. 1740, 109–124 (2018).

Somiya, M. & Kuroda, S. Real-time luminescence assay for cytoplasmic cargo delivery of extracellular vesicles. Anal. Chem. 93, 5612–5620 (2021).

Mangeot, P. E. et al. Protein transfer into human cells by VSV-G-induced nanovesicles. Mol. Ther. 19, 1656–1666 (2011).

Cronin, J., Zhang, X.-Y. & Reiser, J. Altering the tropism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 5, 387–398 (2005).

Frecha, C. et al. Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. Blood 112, 4843–4852 (2008).

Frecha, C. et al. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors. J. Virol. 85, 5975–5985 (2011).

Karampetsou, M. P., Comte, D., Kis-Toth, K., Kyttaris, V. C. & Tsokos, G. C. Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus. PLoS ONE 12, e0186073 (2017).

Hashiguchi, T., Maenaka, K. & Yanagi, Y. Measles virus hemagglutinin: structural insights into cell entry and measles vaccine. Front. Microbiol. 2, 247 (2011).

Gonçalves-Carneiro, D., McKeating, J. A. & Bailey, D. The measles virus receptor SLAMF1 can mediate particle endocytosis. J. Virol. 91, e02255-16 (2017).

Soares, A. R. et al. Gap junctional protein Cx43 is involved in the communication between extracellular vesicles and mammalian cells. Sci. Rep. 5, 13243 (2015).

Schumann, K. et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc. Natl Acad. Sci. USA 112, 10437–10442 (2015).

Hultquist, J. F. et al. A Cas9 ribonucleoprotein platform for functional genetic studies of HIV–host interactions in primary human T cells. Cell Rep. 17, 1438–1452 (2016).

Liu, S. et al. HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR–Cas9 and piggyBac recombinant technologies. Sci. Rep. 8, 8573 (2018).

Zhu, X. et al. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J. Extracell. Vesicles 6, 1324730 (2017).

Hultquist, J. F. et al. CRISPR–Cas9 genome engineering of primary CD4(+) T cells for the interrogation of HIV–host factor interactions. Nat. Protoc. 14, 1–27 (2019).

Modarai, S. R., Kanda, S., Bloh, K., Opdenaker, L. M. & Kmiec, E. B. Precise and error-prone CRISPR-directed gene editing activity in human CD34+ cells varies widely among patient samples. Gene Ther. 28, 105–113 (2021).

Breuer, C. B. et al. In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery. Sci. Rep. 10, 4544 (2020).

Shrivastava, S. et al. Exosome-mediated stable epigenetic repression of HIV-1. Nat. Commun. 12, 5541 (2021).

Cheng, Q. et al. Reprogramming exosomes as nanoscale controllers of cellular immunity. J. Am. Chem. Soc. 140, 16413–16417 (2018).

Campbell, L. A. et al. Gesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex for inactivating the HIV provirus. Mol. Ther. 27, 151–163 (2019).

Sterzenbach, U. et al. Engineered exosomes as vehicles for biologically active proteins. Mol. Ther. 25, 1269–1278 (2017).

Dooley, K. et al. A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties. Mol. Ther. 29, 1729–1743 (2021).

Levy, C. et al. Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells. Mol. Ther. 20, 1699–1712 (2012).

Hendel, A. et al. Chemically modified guide RNAs enhance CRISPR–Cas genome editing in human primary cells. Nat. Biotechnol. 33, 985–989 (2015).

Cornu, T. I., Mussolino, C., Bloom, K. & Cathomen, T. Editing CCR5: a novel approach to HIV gene therapy. Adv. Exp. Med. Biol. 848, 117–130 (2015).

Zou, X. et al. Extracellular vesicles expressing a single-chain variable fragment of an HIV-1 specific antibody selectively target Env(+) tissues. Theranostics 9, 5657–5671 (2019).

Wang, S., Beattie, G. M., Hayek, A. & Levine, F. Development of a VSV-G protein pseudotyped retroviral vector system expressing dominant oncogenes from a lacO-modified inducible LTR promoter. Gene 182, 145–150 (1996).

Yoshida, Y., Emi, N. & Hamada, H. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochem. Biophys. Res. Commun. 232, 379–382 (1997).

Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).

Ai, H. W., Shaner, N. C., Cheng, Z., Tsien, R. Y. & Campbell, R. E. Exploration of new chromophore structures leads to the identification of improved blue fluorescent proteins. Biochemistry 46, 5904–5910 (2007).

Daringer, N. M., Dudek, R. M., Schwarz, K. A. & Leonard, J. N. Modular extracellular sensor architecture for engineering mammalian cell-based devices. ACS Synth. Biol. 3, 892–902 (2014).

Atasoy, D., Aponte, Y., Su, H. H. & Sternson, S. M. A FLEX switch targets Channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mapping. J. Neurosci. 28, 7025–7030 (2008).

Heredia, J. D. et al. Mapping interaction sites on human chemokine receptors by deep mutational scanning. J. Immunol. 200, 3825–3839 (2018).

Shen, Y., Rosendale, M., Campbell, R. E. & Perrais, D. pHuji, a pH-sensitive red fluorescent protein for imaging of exo- and endocytosis. J. Cell Biol. 207, 419–432 (2014).

Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013). </textarea>

        </div>



        <div class="flex2">

            <header>RELATED NEWS</header>

            <div id="related"></div>


        </div>

    </div>

    <script src="/static/script.js"> </script>


</body>

</html>